Skip to content
Search

Latest Stories

Exclusive: ‘Racism is real and still occurring’

A community pharmacist narrates her ordeal of having to deal with a patient who questioned her racial identity, which she wears 'as royalty'...  

By Harpreet Guraya


“I just wanted to ask – do you consider yourself English?” Recently, during a busy day in the community pharmacist world, I was asked this question.

A man asked for a consultation with a chaperone and this was his query.

I was expecting an embarrassing personal health problem or a malicious complaint – both of which I was well versed in dealing with.

However, this took me entirely by shock. But it shouldn’t have done.

Around 43 per cent of GPhC-registered pharmacists come from a black, Asian and minority ethnic (BAME) community. I have worked alongside countless BAME pharmacists myself.

Have there been comments made about language barriers by staff? Yes.

Have there been comments by patients about the colour of our skin ? Yes.

Have colleagues and patients both struggled pronouncing our names? Yes.

Have we been resorted to being identified as “The South Asian pharmacist” ? Yes.

So really there should be no surprise. Of course, my name and the colour of my skin is the first thing someone sees about me. And judges me on.

During this bizarre consultation in front of my colleague, I was instantly belittled to the colour of my skin and origin.

I was at work, in a professional capacity, and not expecting to be questioned on my political opinions or views on 'Rule Britannia'.

In fact, I had no idea about it! For my concerns were serving my local community, getting the abundance of prescription baskets checked and managing my workload.

This patient pounced on probably the only BAME person he knew, which incidentally happened to be his local community pharmacist.

For the rest of my afternoon checking prescriptions, my head swarmed with thoughts around this man and his urgent query.

Something had happened with me but I couldn’t explain it. Racism seemed too harsh of a word.

It’s Covid times and we are reluctant to have face-to-face consultations with people in a small, confined area.

But there we go – questions regarding my identification as being English and the country I was born in justified that risk for this patient.

I was confused and upset, and I felt a sense of social isolation.

Slavery and Britannia? Why yes, I do have opinions. As I’m sure more of “them” from an “ethnic minority” do have.

'Judge me on my work, not on the colour of my skin'

I have great pride in my colour, ancestry and heritage. But whether I consider myself English or not is totally irrelevant when checking Mr Smith’s propranolol or advising Mrs Jones on her rash.

Judge me on my hard work, on me exceeding my targets, on my clinical expertise. My colour is the easiest achievement I’ve had – I’ve been born with it and wear it as royalty.

I know this is not the last encounter I will have with racism at work, and I know my colleagues have experienced a wide array of similar situations based on their colour and ethnicity.

The recent media attention on the lack of Covid-19 risk assessments being carried out on the at-risk group of BAME pharmacists has only heightened this awareness.

Discrimination is a sour but long standing truth of the world we live in and the history we have.

We need to see more BAME individuals in NHS leadership roles helping to tackle these disparities and health inequalities.

This year will be remembered for many things, but one thing I hope is not forgotten is the acceptance that racism is real and still occurring.

Harpreet Guraya is a superintendent pharmacist based in north-east England.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less